Retractable Technologies, Inc. (RVP)
Stock Price Chart
Key Info
| Market Cap | 285.31M |
| Revenue (ttm) | 45.07M |
| Net Income (ttm) | 3.60M |
| Shares Out | 32.68M |
| EPS (ttm) | 0.08 |
| PE Ratio | 109.13 |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
Stock Quote
| Trading Day | Aug 14, 2020 |
| Last Price | $8.73 |
| Previous Close | $9.57 |
| Change ($) | -0.84 |
| Change (%) | -8.78% |
| Day's Open | 9.94 |
| Day's Range | 8.61 - 10.00 |
| Day's Volume | 602,021 |
| 52-Week Range | 0.71 - 13.65 |
More Stats
| Market Cap | 285.31M |
| Enterprise Value | 272.63M |
| Earnings Date (est) | n/a |
| Ex-Dividend Date | n/a |
| Shares Outstanding | 32.68M |
| Float | 12.05M |
| EPS (basic) | 0.09 |
| EPS (diluted) | 0.08 |
| FCF / Share | 0.13 |
| Dividend | n/a |
| Dividend Yield | n/a |
| Earnings Yield | 0.92% |
| FCF Yield | 1.48% |
| Payout Ratio | n/a |
| Shares Short | 1.77M |
| Short Ratio | 1.53 |
| Short % of Float | 13.19% |
| Beta | 2.03 |
| PE Ratio | 109.13 |
| Forward PE | n/a |
| P/FCF Ratio | 67.70 |
| PS Ratio | 6.33 |
| PB Ratio | 11.38 |
| Revenue | 45.07M |
| Operating Income | 3.63M |
| Net Income | 3.60M |
| Free Cash Flow | 4.21M |
| Net Cash | 12.68M |
| Net Cash / Share | 0.39 |
| Gross Margin | 31.37% |
| Operating Margin | 8.05% |
| Profit Margin | 6.40% |
| FCF Margin | 9.35% |
| ROA | 6.14% |
| ROE | 13.29% |
| ROIC | n/a |
Analyst Summary
Analyst Consensus: n/a
Financial Performance
Financial Overview
| Year | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 41.80 | 33.27 | 34.49 | 29.83 | 29.55 | 34.52 | 30.79 | 33.64 | 32.10 | 36.22 |
| Revenue Growth | 25.61% | -3.53% | 15.65% | 0.93% | -14.39% | 12.13% | -8.5% | 4.8% | -11.37% | - |
| Gross Profit | 14.14 | 10.22 | 9.97 | 10.34 | 10.57 | 12.02 | 10.31 | 11.18 | 10.90 | 12.52 |
| Operating Income | 2.97 | -1.33 | -3.78 | -3.51 | 4.52 | -2.16 | -5.93 | -3.94 | 1.61 | 2.50 |
| Net Income | 3.15 | -1.34 | -3.74 | -3.69 | 4.31 | -2.35 | -6.21 | -4.13 | 1.42 | 2.40 |
| Shares Outstanding | 32.67 | 32.67 | 31.96 | 29.35 | 27.82 | 27.38 | 27.00 | 26.22 | 24.17 | 23.87 |
| Earnings Per Share | 0.07 | -0.06 | -0.14 | -0.15 | 0.20 | -0.12 | -0.26 | -0.19 | 0.02 | 0.04 |
| EPS Growth | - | - | - | - | - | - | - | - | -50% | - |
| Operating Cash Flow | 2.19 | -1.20 | -2.92 | -0.79 | -3.25 | -3.87 | 2.93 | 0.16 | 5.51 | 8.73 |
| Capital Expenditures | -0.63 | -0.38 | -0.09 | -1.95 | -1.47 | -1.01 | -0.28 | -0.51 | -0.83 | -0.17 |
| Free Cash Flow | 1.56 | -1.58 | -3.01 | -2.74 | -4.72 | -4.88 | 2.65 | -0.35 | 4.69 | 8.56 |
| Cash & Equivalents | 13.71 | 12.63 | 14.88 | 16.20 | 18.05 | 22.73 | 27.63 | 25.96 | 25.67 | 23.27 |
| Total Debt | 2.64 | 3.05 | 3.49 | 3.93 | 3.67 | 3.57 | 3.82 | 4.14 | 4.76 | 4.82 |
| Net Cash / Debt | 11.07 | 9.59 | 11.39 | 12.27 | 14.38 | 19.16 | 23.81 | 21.82 | 20.91 | 18.44 |
| Assets | 39.18 | 36.96 | 38.16 | 38.78 | 42.29 | 45.35 | 49.10 | 47.63 | 48.92 | 53.19 |
| Liabilities | 10.64 | 11.34 | 10.98 | 10.67 | 11.51 | 18.52 | 20.20 | 11.90 | 10.27 | 14.29 |
| Book Value | 28.54 | 25.61 | 27.17 | 28.11 | 30.78 | 26.83 | 28.90 | 35.73 | 38.65 | 38.90 |
Company Profile
Company Details
| Full Name | Retractable Technologies, Inc. |
| Country | United States |
| Employees | 135 |
| CEO | Thomas J. Shaw |
Stock Information
| Ticker Symbol | RVP |
| Stock Exchange | NYSE American |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Unique Identifier | NYSEAMERICAN: RVP |
| IPO Date | May 4, 2001 |
Description
Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other medical products for the healthcare industry in the United States, rest of North and South America, and internationally. It principally offers VanishPoint safety products comprising tuberculin, insulin, autodisable, and allergy antigen syringes; IV catheters; blood collection tube holders; blood collection sets; and Patient Safe safety medical products, including syringes and Luer caps. The company also engages in developing retractable needles and syringes, glass syringes, dental syringes, IV catheter introducers, and blood collection sets, as well as EasyPoint needles. Retractable Technologies, Inc. serves healthcare providers, such as acute care hospitals, alternate care facilities, doctors' offices, clinics, emergency centers, surgical centers, long-term care facilities, veterans administration facilities, military organizations, public health facilities, and prisons. The company distributes its products through general line and specialty distributors, as well as through international distributors; and a direct marketing network. Retractable Technologies, Inc. was incorporated in 1994 and is headquartered in Little Elm, Texas.